Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (296)

« Back to Publications

Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.

Brook MO. et al, (2024), Transplantation, 108, 2278 - 2286

Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis.

Shankar S. et al, (2022), Nat Commun, 13

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients

Bottomley MJ. et al, (2022)

Study Dataset for mHLA-DRd and Cancer Risk

Bottomley M. et al, (2021)

CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.

Arroyo Hornero R. et al, (2020), Commun Biol, 3

Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01.

Gu Y. et al, (2019), Nat Commun, 10

Isolation of Human Regulatory T Lymphocytes by Fluorescence-Activated Cell Sorting.

Milward K. et al, (2019), Methods Mol Biol, 1899, 43 - 54

Immune Tolerance and Rejection in Organ Transplantation.

Stolp J. et al, (2019), Methods Mol Biol, 1899, 159 - 180

CD45RA identifies TSDR demethylated regulatory T cells with a stable phenotype and suppressive cytokine profile

(2018), 26th International Congress of The Transplantation Society (TTS 2016)

Regulatory T cells for tolerance.

Kawai K. et al, (2018), Hum Immunol, 79, 294 - 303

The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells.

Wallin EF. et al, (2018), Front Immunol, 9

How to Escape the Immune Response: What Tumors Teach to Transplant Physicians/Immunologists.

Claisse G. et al, (2017), Transplantation, 101, 2825 - 2829

Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders.

Vanhove B. et al, (2017), Antibodies (Basel), 6

Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses.

Zaitsu M. et al, (2017), JCI Insight, 2

Enhancing human regulatory T cells in vitro for cell therapy applications.

Milward KF. et al, (2017), Immunol Lett, 190, 139 - 147

Load More

1
2
3
4
5
6
7
...
»